Magnera Corp Q4 FY2025 earnings call

Key Takeaways

• Strategy to be a leader in advanced specialty materials is yielding positive results, with success in bid cycles and gaining share in chosen markets.
• Macroeconomic conditions in operating regions are challenging as fiscal year 2026 begins.
• Focus on controllable factors with improvements in synergy run rate performance and progress with Project CORE.

Financial Outcomes

• Fourth quarter sales: $839 million, adjusted EBITDA: $90 million. Full year: revenues $3.2 billion, adjusted EBITDA $362 million, free cash flow $126 million.

Customer Successes

• Personal care: Product mix enhancements, adult incontinence with mid-single-digit growth. Consumer solutions: Increased demand for wipes and infrastructure, sales of infection prevention wipes up 10% YOY. Cable wrap and specialty solutions: Benefiting from electrification and infrastructure growth. Sustainability: Advanced material solutions for wipes, tea/coffee filtration, and compostable offerings.

Transformation Phase

• Entering optimization phase with integrated commercial teams, standardized operational metrics/processes, and ongoing efficiency initiatives.

Rest of World: Revenue declined 3% for the quarter, with adjusted EBITDA increasing $4 million. Americas: Revenues were down 9% for the quarter, and adjusted EBITDA declined $5 million; however, headwinds were partially offset by stronger demand in infrastructure and wipes end markets for the full year. In terms of revenue contribution, consumer solutions portfolio increased from 51% to 53% of total revenue.

• Fiscal 2026 EBITDA growth approximately 9% driven by synergy realization, Project CORE initiatives, and product mix/innovation.
• Free cash flow range $90 million to $110 million, including $80 million capital investments ( $10 million IT conversion CapEx).
• Prudent assessment of near-term environment and disciplined execution of operational and financial strategies.

• Macro-economic challenges in operating regions.
• External market softness impacting volumes.
• Risks related to achieving synergy targets and Project CORE outcomes.

Q: Elaborate on EBITDA drivers and margin expansion.

A: Margin expansion is driven by continued synergy realization, with 70%-75% of remaining unrealized synergies to be realized next year, and Project CORE ramping up with full realization in Q2, 3, 4.

Q: Share gains in bid season and portfolio mix in 2026.

A: Success in bid season, focus on premium products, consumer solutions portfolio shifting from 51% to 53% of total revenue, with emphasis on products like lamination and soft applications in personal care.

Q: Free cash flow range breakdown.

A: Includes $80 million capital expenditures ($10 million IT-related integration costs), ~$30-35 million cash taxes, with working capital assumed flat for 2026.

Q: Fiscal 2025 volume growth and 2026 quarterly tempo.

A: Fiscal 2025 volume decline ~3.5%-4%, 2026 synergy realization and Project CORE impact with most benefit in Q3, Q4 but phased in from Q1 onwards.

Q: Debt paydown rationale and cash use options.

A: Focus on debt reduction as part of capital allocation, with discussions on Board regarding cash use options but emphasis on deleveraging.

Q: D&A and share count, CapEx projection.

A: D&A in Q4 due to purchase accounting finalization, share count flat, CapEx in line with plan with focus on maintenance, safety, and growth projects within 2% - 3% of sales.

Q: Integration process progress and remaining tasks.

A: Procurement progress with savings seen in Q3-Q4, HR engagement and benefits implementation, Project CORE impact on all regions except Asia, progress on TSA separation ahead of schedule.